PTC Therapeutics, Inc.
(NASDAQ : PTCT)

( )
PTCT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.79%171.561.2%$575.26m
CELGCelgene Corporation
-0.75%88.951.2%$554.24m
GILDGilead Sciences, Inc.
-0.99%73.700.9%$441.10m
BIIBBiogen Inc.
-1.13%263.021.2%$436.72m
REGNRegeneron Pharmaceuticals, Inc.
-0.50%314.252.7%$242.24m
INCYIncyte Corporation
-0.90%68.432.5%$236.48m
VRTXVertex Pharmaceuticals Incorporated
-0.88%158.151.9%$224.32m
ALXNAlexion Pharmaceuticals, Inc.
-3.54%107.782.0%$215.70m
NKTRNektar Therapeutics
-4.37%86.216.0%$196.49m
ILMNIllumina, Inc.
-0.50%244.603.5%$185.23m
AAgilent Technologies, Inc.
-0.63%67.541.5%$152.87m
ALNYAlnylam Pharmaceuticals, Inc
1.34%97.489.8%$137.98m
BLUEBluebird Bio, Inc.
0.00%170.5015.8%$135.45m
EXASExact Sciences Corporation
1.54%47.5225.7%$108.85m
BMRNBioMarin Pharmaceutical Inc.
-1.58%82.304.4%$107.66m

Company Profile

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel medicines using its expertise in RNA biology. The company's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders and oncology. It is focused on developing treatments to fundamentally change the lives of patients living with rare genetic disorders. The company was founded by Allan S. Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.